(IN BRIEF) EQT Life Sciences announces the acquisition of its portfolio company, Amolyt Pharma, by Alexion, AstraZeneca Rare Diseases, for…
(IN BRIEF) Private equity firm EQT Life Sciences has raised €260m in assets for its inaugural LSP Dementia Fund, which…